Researching Ways to Make Memories Last a Lifetime

Every 4 seconds another person in the world develops Alzheimer’s disease, a statistic released by the World Health Organization in its 2012 report, Dementia, A Public Health Priority, on April 11 and highlighted by Dr. Frank LaFerla, Director of the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), that same evening in his presentation, Researching Ways to Make Memories Last A Lifetime, at the 18th UCI Distinguished Lecture Series on Brain, Learning and Memory, co-hosted by the UCI Center for Neurobiology, Learning and Memory and UCI MIND. more >

A Night at Sardi’s Features Dr. Frank LaFerla

Dr. Frank LaFerla , Director of UCI MIND, addressed the 1,000+ prominent political and entertainment industry leaders – in addition to celebrities – who gathered on March 21, 2012, at the Beverly Hilton to recognize advances in the fight against Alzheimer’s disease and rally around the growing movement to end the disease.  This annual Alzheimer’s Association gala has raised over $19 million since its inception to advance cutting-edge research, increase awareness, and address the needs of Americans living with the disease and their caregivers. more >

A Time of Your Life Raises Funds for UCI MIND

Over 500 guests enjoyed A Time of Your Life Saturday, March 10th, and raised much-needed funding to support research at UCI MIND.  Thank you to sponsor San Clemente Villas by the Seas for this video that shares the sights and sounds of the evening. more >

More Evidence that Omega-3 Fatty Acids Support Brain Health

A study published in the February 28 issue of the journal Neurology provides more evidence that high dietary consumption of omega-3 fatty acids, found in fish such as salmon and tuna, may protect the brain against cognitive impairment.

The research team, led by Dr. more >

Mild Cognitive Impairment and Alzheimer’s Disease – Video

Learn about Mild Cognitive Impairment, Alzheimer’s disease, and ways to support research at UCI MIND

Is dementia the same as Alzheimer’s disease?  Dr. Cordula Dick-Muehlke, Director of Education at UCI MIND, answers this common question and describes Mild Cognitive Impairment, the transitional stage between normal aging and dementia. more >

UCI MIND Scientist and Caregiver on Alzheimer’s


  more >

Cancer drug rapidly clears amyloid plaques

Researchers at Case Western Reserve University School of Medicine have demonstrated that bexarotene, an FDA-approved drug for the  treatment of skin cancer, dramatically and rapidly clears amyloid plaques from the brains of mice bred with Alzheimer’s disease.  Led by Gary Landreth, Ph.D.,  the study just published on line in Science Express, found that bexarotene not only enhanced clearance of beta amyloid, an abnormal protein associated with Alzheimer’s disease, but also improved some cognitive and behavioral functions. more >

Obama boosts Alzheimer's funding by $130 million

Kathleen Sebelius, Secretary of Health and Human Services, announced today that the Obama administration would increase funding for Alzheimer’s disease research by $130 million.   An extra $50 million will be made available immediately, and another $80 million will be added to the fiscal year 2013 federal budget to be released next week.  In total, this funding represents a 25% increase in funding for Alzheimer’s disease research over the next two years.  An additional $25 million will be allocated for caregiver support, provider education, public awareness, and improvements in data infrastructure.  “We can’t wait to confront the growing threat that Alzheimer’s disease poses to American families and to our nation as a whole,” noted Sebelius.   Increased funding comes on the heels of the recent announcement that first goal of  the National Alzheimer’s Project Act is

to prevent and effectively treat Alzheimer’s disease by 2025

Nationwide, 5.4 million people have AD and rely on 14.9 million close family members and friends for care.  In California, AD currently affects nearly 500,000 people, a number that is expected to escalate to 1.1 million by 2030.  With an average of three caregivers supporting each of these 1.1 million people, the number of Californians coping with AD will total an estimated 4.4 million in 2030. more >

Aimee Pierce, M.D., Named Medical Director

Dr. Aimee Pierce, Assistant Clinical Professor in UCI’s Department of Neurology, has been named Medical Director of the UCI MIND Memory Assessment Clinic.  Hailing from Eugene, Oregon, Dr. Pierce earned her B.S. in Biology at the California Institute of Technology in Pasadena, CA, and her M.D. more >

UCI MIND Launches MIND Matters Club

Dr. Frank LaFerla, Dr. Margaret Gatz, and Dr. Cordula Dick-Muehlke at MIND Matters Club Launch

On January 19, UCI MIND launched the MIND Matters Club at the home of Burton and Linda Young, who graciously hosted this inaugural gathering of individuals who have committed to  giving $1,906 or more annually to UCI MIND.  Guests gathered to hear Dr. more >